Alemtuzumab-containing reduced intensity conditioning allogenic hematopoietic stem cell transplantation in a case of primary progressive multiple sclerosis

Autor: AlKhaja, Mohamed, Abanmy, Abdulaziz, AlKhdairi, Ahmed, AlRasheedi, Sami, AlZahrani, Hazza, AlKhawajah, Mona
Zdroj: In Multiple Sclerosis and Related Disorders October 2018 25:334-336
Databáze: ScienceDirect